Pallister-Killian syndrome [i(12p)]: first pre-natal diagnosis using cordocentesis in the second trimester confirmed

J Chiesa1, M Hoffet, O Rousseau

  • 1Laboratoire de Biologie Cellulaire et de Cytogénétique Moléculaire, UPRES JE 1952, Faculté de Médecine, Université Montpellier I, France.

Clinical Genetics
|November 27, 1998
PubMed

Insights

Pallister Killian syndrome (PKS), a mosaic isochromosome 12p condition, was diagnosed pre-natally using fetal blood cells and FISH. Consistent ultrasound findings aid in early PKS recognition.

Area of Science:

  • Genetics
  • Prenatal Diagnosis
  • Human Malformations

Background:

  • Pallister Killian syndrome (PKS) is characterized by mosaicism for an extra isochromosome 12p (i(12p)).
  • Early and accurate diagnosis is crucial for managing PKS.

Observation:

  • This study reports the first prenatal diagnosis of PKS using fetal blood cells obtained via second-trimester cordocentesis.
  • In situ hybridization and fluorescence in situ hybridization (FISH) were employed to detect the i(12p) in fetal cells.

Findings:

  • FISH analysis confirmed the presence of i(12p) in a mosaic pattern.
  • A literature review identified 27 prenatal PKS cases, correlating specific ultrasound findings with the condition.
  • Consistent prenatal ultrasound markers for PKS include hypertelorism, broad neck, short limbs, limb abnormalities, diaphragmatic hernia, and hydramnios.

Implications:

  • Prenatal diagnosis of PKS is feasible using cordocentesis and cytogenetic analysis.
  • Recognizing characteristic ultrasound findings can prompt further investigation with FISH for i(12p).
  • Early PKS detection allows for timely genetic counseling and planning for affected infants.